Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marirosa Mora

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
The Journal of Infectious Diseases|December 18, 2008
Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigmImmaculada Margarit, Cira Daniela Rinaudo, Cesira L Galeotti, et al.
Plos Pathogens|May 10, 2014
SslE elicits functional antibodies that impair in vitro mucinase activity and in vivo colonization by both intestinal and extraintestinal Escherichia coli strainsBarbara Nesta, Maria Valeri, Angela Spagnuolo, et al.
Molecular & Cellular Proteomics : MCP|January 31, 2012
Multi high-throughput approach for highly selective identification of vaccine candidates: the Group A Streptococcus caseGiuliano Bensi, Marirosa Mora, Giovanna Tuscano, et al.
Science (New York, N.Y.)|July 5, 2005
Identification of a universal Group B streptococcus vaccine by multiple genome screenDomenico Maione, Immaculada Margarit, Cira D Rinaudo, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2002
Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiaeHerve Tettelin, Vega Masignani, Michael J Cieslewicz, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2005
Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial "pan-genome"Hervé Tettelin, Vega Masignani, Michael J Cieslewicz, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
The Journal of Infectious Diseases|December 18, 2008
Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigmImmaculada Margarit, Cira Daniela Rinaudo, Cesira L Galeotti, et al.
Plos Pathogens|May 10, 2014
SslE elicits functional antibodies that impair in vitro mucinase activity and in vivo colonization by both intestinal and extraintestinal Escherichia coli strainsBarbara Nesta, Maria Valeri, Angela Spagnuolo, et al.
Molecular & Cellular Proteomics : MCP|January 31, 2012
Multi high-throughput approach for highly selective identification of vaccine candidates: the Group A Streptococcus caseGiuliano Bensi, Marirosa Mora, Giovanna Tuscano, et al.
Science (New York, N.Y.)|July 5, 2005
Identification of a universal Group B streptococcus vaccine by multiple genome screenDomenico Maione, Immaculada Margarit, Cira D Rinaudo, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2002
Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiaeHerve Tettelin, Vega Masignani, Michael J Cieslewicz, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 21, 2005
Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial "pan-genome"Hervé Tettelin, Vega Masignani, Michael J Cieslewicz, et al.
Pageof 3